ASCO 2026 wasn’t just about new data—it highlighted where oncology is headed next. From breakthrough in vivo CAR-T results and RAS-targeted therapies to the growing influence of Chinese biotech on the global stage, this year’s meeting showcased the evolving future of cancer care. Listen to the recap: https://www.fiercepharma.com/pharma/behind-headlines-asco-2026
More Tips From The Bandish Group
The Skills Employees Need to Succeed in the Age of AI
◆
Artificial intelligence is changing the workplace, but the skills employees need in the age of AI are not necessarily new.…
November 19, 2026
Read More
#455: Interview Questions for Hiring Managers: How to Identify the Right Candidate
◆
An effective interview is about more than confirming what’s already listed on a candidate’s resume. It’s an opportunity for hiring…
November 18, 2026
Read More